Yuqi He

机构：Hong Kong Polytechnic University, Zunyi Medical University · ORCID：0009-0004-3582-9502

发表论文 19 篇 · 总被引 257 次 · h-index 8

代表论文

• Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways (2016 · Acta Pharmacologica Sinica · 被引 91)
• Trilobatin Protects Against Aβ25–35-Induced Hippocampal HT22 Cells Apoptosis Through Mediating ROS/p38/Caspase 3-Dependent Pathway (2020 · Frontiers in Pharmacology · 被引 47)
• Exploring microRNAs in diabetic chronic cutaneous ulcers: Regulatory mechanisms and therapeutic potential (2020 · British Journal of Pharmacology · 被引 34)
• Construction of in vitro liver-on-a-chip models and application progress (2024 · BioMedical Engineering OnLine · 被引 33)
• MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer (2023 · Scientific Reports · 被引 13)
• MicroRNAs in the Regulation of RIG-I-like Receptor Signaling Pathway: Possible Strategy for Viral Infection and Cancer (2023 · Biomolecules · 被引 13)